Company Overview
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
Why Investors Should Care
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $5.81B (+0.4% YoY); net profit $-386.00M.
- Trailing 12 Months Year-on-year growth — revenue +1.0%, earnings -659.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -1.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -1.38% |
| 1 Year: | 1.00% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -659.42% |
Stock Price Performance
| 1 Year: | +41.13% |
| 6 Months: | +31.41% |
| 3 Months: | -18.89% |
| 1 Month: | -13.43% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)41.18 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -1.4% CAGR over 5 years.
- Trading 33.1% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CC The Chemours Company R2K | 18.63 | -6.82 | $2.80B | 1.59% | - | -103.01% | -1.38% | - |
| 2 | LIN Linde plc NDXSPX | 522.54 | 34.65 | $241.59B | 1.22% | 12.46% | 18.23% | 13.90% | 18.47% |
| 3 | NEM Newmont Corporation SPX | 94.75 | 12.29 | $101.15B | 1.04% | - | 25.83% | 6.53% | 20.15% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 61.95 | 32.78 | $89.06B | 0.88% | 12.50% | 15.63% | 1.35% | -1.26% |
| 5 | SHW The Sherwin-Williams Company SPX | 328.50 | 31.56 | $81.02B | 1.01% | 21.93% | 60.72% | 6.18% | 8.26% |
| 6 | ECL Ecolab Inc. SPX | 269.75 | 36.55 | $75.92B | 1.10% | 14.29% | 22.43% | 6.17% | 9.18% |
| 7 | CRH CRH plc SPX | 103.91 | 19.28 | $69.43B | 1.47% | 10.97% | 15.81% | 6.41% | 9.30% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 299.40 | 31.55 | $66.67B | 2.57% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | CTVA Corteva, Inc. SPX | 84.91 | 45.90 | $56.79B | 0.95% | - | 5.14% | 2.86% | 9.94% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | 1.44B | 1.59B | 1.58B | 1.57B | 1.73B | 1.82B | 1.63B | 1.46B | 1.38B | 1.41B | 1.39B | 1.35B | 1.30B | 1.09B | 1.23B | 1.44B | 1.66B | 1.68B | 1.76B | 1.92B | 1.78B | 1.34B | 1.55B | 1.66B | 1.50B | 1.37B | 1.36B | 1.55B | 1.51B | 1.36B | 1.37B | 1.61B | 1.50B | 1.33B | 1.38B |
| Gross Profit | - | 202.00M | 267.00M | 342.00M | - | 356.00M | 438.00M | 465.00M | - | 537.00M | 557.00M | 477.00M | - | 296.00M | 323.00M | 294.00M | - | 298.00M | 199.00M | 257.00M | 297.00M | 264.00M | 427.00M | 486.00M | 497.00M | 432.00M | - | 368.00M | 410.00M | 273.00M | - | 284.00M | 308.00M | 286.00M | 265.00M | 236.00M | 278.00M | 233.00M | - | 212.00M |
| Net Income | -86.00M | 51.00M | -18.00M | 204.00M | -230.00M | 150.00M | 161.00M | 207.00M | 228.00M | 297.00M | 281.00M | 275.00M | 142.00M | 94.00M | 96.00M | 76.00M | -317.00M | 100.00M | 24.00M | 76.00M | 96.00M | 66.00M | 214.00M | 234.00M | 201.00M | 240.00M | -97.00M | 145.00M | -376.00M | 12.00M | -18.00M | 54.00M | 60.00M | -32.00M | -11.00M | -5.00M | -380.00M | 46.00M | -47.00M | -29.00M |
| Diluted EPS | -0.48 | 0.28 | -0.10 | 1.11 | -1.26 | 0.79 | 0.84 | 1.08 | 1.19 | 1.58 | 1.53 | 1.51 | 0.81 | 0.55 | 0.57 | 0.46 | -1.94 | 0.61 | 0.15 | 0.46 | 0.57 | 0.39 | 1.27 | 1.43 | 1.26 | 1.52 | -0.65 | 0.96 | -2.52 | 0.08 | -0.12 | 0.36 | 0.39 | -0.22 | -0.08 | -0.03 | -2.53 | 0.31 | -0.31 | -0.19 |
| R&D Expense | - | 23.00M | 17.00M | 19.00M | - | 19.00M | 21.00M | 20.00M | - | 20.00M | 20.00M | 20.00M | - | 22.00M | 19.00M | 20.00M | - | 24.00M | 20.00M | 22.00M | 24.00M | 27.00M | 27.00M | 30.00M | 25.00M | 32.00M | - | 26.00M | 28.00M | 28.00M | - | 28.00M | 26.00M | 29.00M | - | 27.00M | 28.00M | 26.00M | - | 26.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.86B | 6.43B | 5.72B | 5.40B | 6.18B | 6.64B | 5.53B | 4.97B | 6.34B | 6.83B | 6.08B | 5.78B | 5.81B |
| Gross Profit | 1.46B | 1.36B | 955.00M | 1.10B | 1.75B | 1.97B | 1.06B | 1.07B | 1.38B | 1.62B | 1.30B | 1.14B | 902.00M |
| Net Income | 423.00M | 400.00M | -90.00M | 7.00M | 746.00M | 995.00M | -52.00M | 219.00M | 608.00M | 578.00M | -253.00M | 69.00M | -386.00M |
| Diluted EPS | 2.34 | 2.21 | -0.50 | 0.04 | 3.91 | 5.45 | -0.32 | 1.32 | 3.60 | 3.65 | -1.70 | 0.46 | -2.57 |
| R&D Expense | 164.00M | 143.00M | 97.00M | 81.00M | 81.00M | 82.00M | 80.00M | 93.00M | 107.00M | 118.00M | 108.00M | 109.00M | 108.00M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 5.96B | 6.30B | 6.06B | 7.29B | 7.36B | 7.26B | 7.08B | 7.55B | 7.64B | - | - | - | 8.24B | 7.51B | 7.38B | 7.46B | 7.55B | 7.38B |
| Total Equity | 3.17B | 3.22B | 3.67B | 126.00M | 100.00M | 860.00M | 1.01B | 689.00M | 813.00M | 1.08B | 1.11B | - | - | 749.00M | 721.00M | 571.00M | 566.00M | 228.00M | 274.00M | 250.00M |
| Cash & Equivalents | - | 0 | 0 | 366.00M | 902.00M | 1.56B | 1.20B | 943.00M | 1.10B | 1.45B | 1.10B | - | - | - | 1.20B | 713.00M | - | - | - | 670.00M |
| Long Term Debt | - | - | 0 | 3.92B | 3.53B | 4.10B | 3.96B | 4.03B | 4.00B | 3.72B | 3.59B | - | - | - | 3.99B | 4.06B | 4.07B | 4.11B | 4.10B | 4.10B |
| Total Liabilities | - | - | 2.29B | 6.17B | 5.96B | 6.43B | 6.34B | 6.56B | 6.27B | 6.47B | 6.53B | - | - | 7.20B | 7.52B | 6.94B | 6.81B | 7.23B | - | 7.13B |
| Current Liabilities | - | - | 1.40B | 1.47B | 1.77B | 1.65B | 1.71B | 1.54B | 1.44B | 1.86B | 1.89B | 1.75B | 2.19B | 2.92B | 2.49B | 1.82B | 1.67B | 1.83B | 1.87B | 1.69B |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 798.00M | 505.00M | 182.00M | 594.00M | 640.00M | 1.14B | 650.00M | 807.00M | 814.00M | 755.00M | 556.00M | -633.00M | 264.00M |
| Investing Cash Flow | -424.00M | -560.00M | -497.00M | 357.00M | -370.00M | -487.00M | -483.00M | -234.00M | 220.00M | -284.00M | -229.00M | -353.00M | -206.00M |
| Financing Cash Flow | -374.00M | 55.00M | 687.00M | -396.00M | 352.00M | -993.00M | -419.00M | -449.00M | -554.00M | -686.00M | 172.00M | -36.00M | -126.00M |
| Capital Expenditure | -438.00M | -604.00M | -519.00M | -338.00M | -411.00M | -498.00M | -481.00M | -267.00M | -277.00M | -307.00M | -370.00M | -360.00M | -213.00M |
| Free Cash Flow | 360.00M | -99.00M | -337.00M | 256.00M | 229.00M | 642.00M | 169.00M | 540.00M | 537.00M | 448.00M | 186.00M | -993.00M | 51.00M |
| Share Buybacks | - | - | - | 0 | 106.00M | 644.00M | 322.00M | 0 | 173.00M | 495.00M | 69.00M | - | - |
| Dividends Paid | 0 | 0 | 105.00M | 22.00M | 22.00M | 148.00M | 164.00M | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 21.3% | 21.1% | 16.7% | 20.4% | 28.2% | 29.7% | 19.2% | 21.5% | 21.8% | 23.7% | 21.4% | 19.8% | 15.5% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Margin % | 6.2% | 6.2% | -1.6% | 0.1% | 12.1% | 15.0% | -0.9% | 4.4% | 9.6% | 8.5% | -4.2% | 1.2% | -6.6% |
| ROE % | 13.1% | 10.9% | -71.4% | 7.0% | 86.7% | 98.1% | -7.5% | 26.9% | 56.2% | 52.2% | -35.1% | 12.1% | -154.4% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 14.89% | 22.39M | $408.88M |
| 2 | Vanguard Portfolio Management LLC | 6.87% | 10.33M | $188.59M |
| 3 | Vanguard Capital Management LLC | 4.50% | 6.77M | $123.73M |
| 4 | State Street Corporation | 4.07% | 6.12M | $111.84M |
| 5 | Ameriprise Financial, Inc. | 3.22% | 4.84M | $88.36M |
| 6 | American Century Companies Inc | 2.94% | 4.42M | $80.66M |
| 7 | JPMORGAN CHASE & CO | 2.53% | 3.80M | $69.42M |
| 8 | Wolf Hill Capital Management, LP | 2.45% | 3.69M | $67.39M |
| 9 | Geode Capital Management, LLC | 2.40% | 3.60M | $65.83M |
| 10 | Goldman Sachs Group Inc | 2.00% | 3.01M | $55.05M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CC
Chemours (CC) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOWXlON1FKOTd6eFlNckVWUHNqSTk3eFkwaHVScmVzbFBHdU9rblZDRTB1QnJuZnVnVDVYUjZYSmoxdTZESDNFckxCeGRndnllWXItMlU0RDJFU2ZjdXlncHhmLVo1cVFBeXNKS2hpa0lSYl9zN0FOTmpCUHVTMWdpUWtsNllfQnVGZ21YSE…
Chemours (CC) director Courtney Mather receives 1,401 deferred stock units grant - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOQy1SOTJ0bU80dDhOeFlxM1ZVME1FamJqeGRrSEw3dUQyam5hQ0xVVTBiazFOWUlPOVdBMHV3ZnUzdTBndFNIR1ZVT05taEdVZmtmbE5RVDVEZWQxZ0o2VVZEb0ZDLVE4SENWSV84Y1M0U0xPamNfbjZuZ243M1FWMGRYekZUeGdxaHlJSl…
The Chemours Company (NYSE:CC) Shares Fly 27% But Investors Aren't Buying For Growth - simplywall.st
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNTTYxOG82VmRjNVc2QzZpQjNEeVVORlF2c0tvcXMtaldWNWhmbHJNNW8xU05xT1ZYUkFoamJNTjVSU3N3cHEySjlQV2R1U1lYSlRBOER6UzFKMXN4eE9uTVpwMHU4SVZIMlpKdlpXOC1QdlZUcWRqVmpNX20xV0pQMi12TC1FTklXQVBYbU…
Chemours Company (CC) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNcGE1R1BoZTMwWjlKc2pZekhMVXNGVVVPVV9aVXlBXzFMdi1rQW1kZm5BNXN0UGZNdU50emNYODd2Q0NuRURJTzRMOF9abHFKbmtsa1ZhTDhHMWhWVzlDUXBWendCcDBNdjRPY2tOejk1UTZCd1Z0SjVhUEF3SUZKNVg2dzVVUWUzUUFCYz…
Trump’s Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30 - 24/7 Wall St.
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPalZHbUJqeWtUSmVWMnNtNDlHNjZwb3FOZlZyQ1JQeE9BNk5aWU9aQmdKM2xlLTRSYXlQQVZGVGNnU0FzT1Z6T1JxN3g5S1NXQW1wTEkzLVloMWJzZHVBYWQtdEN1Sktqelhvd0NqY29pVFlrUTlSaXhGSldNbUNRdWx5Skl6WGFqaVhmU3…
Chemours (CC) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNeTljbDUxWEk0ek1ydUFnZDBUdWd1d3VobGdBM2lGV2x4WHpoLUpxeFJoZXM2ZlhHTTlLMnZkOU9GRzl0am1KUFdUQWdlaTZ2Sm1DWjdscXpia0N4MV9ISXVNR1AyT0ttNnA1dlpucW1rT1k3Q2lDRGhmZ1lOR2x3UXdLbzlTYWwtcE5KZz…
CC — Frequently Asked Questions
What is the current share price of The Chemours Company (CC)?
As of 2026-07-14 21:23 PDT, The Chemours Company (CC) trades at $18.63 on NYSE. Its 52-week range is $10.39 to $27.84.
What is the market capitalisation of CC?
The Chemours Company (CC) has a market capitalisation of $2.80B on NYSE.
What is the P/E ratio of CC?
CC trades at a trailing price-to-earnings (P/E) ratio of -6.82. The industry average P/E is 22.91. Its price-to-book (P/B) ratio is 15.38.
Does CC pay a dividend?
The Chemours Company (CC) currently offers a dividend yield of 1.59%.
What is the return on equity (ROE) of CC?
CC has a return on equity (ROE) of -103.01%.
Is CC a good stock to buy?
This page provides a data-driven analysis of The Chemours Company (CC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.